This Nasdaq-Listed Drug Company Is Set to Buy $700 Million in BNB
-
最新报道：A pharmaceutical company reportedly purchased $700 million worth of Binance Coin (BNB) at its all-time high price, according to blockchain analytics firm Lookonchain. The transaction, involving 3.8 million BNB tokens, occurred when BNB was trading near its peak of $686. The buyer's identity remains undisclosed, but the massive purchase has sparked speculation about potential institutional interest in the cryptocurrency. This move comes as BNB, the native token of Binance Smart Chain, has seen significant growth in adoption and utility within the decentralized finance (DeFi) ecosystem. The large-scale acquisition highlights increasing corporate involvement in the crypto space.
下一篇
Upbit Lists Maple Finance SYRUP HUMA Tokens July 25 Trading Volume Surges $800M Driven by Listing
- Upbit has listed Maple Finance (MPL) and Syrup (SYP) tokens, with Huma Finance (HUMA) join...
24小时热点
热点专题
407366